Emerging Strategies and Agents to Lower Cardiovascular Risk by Increasing High Density Lipoprotein Cholesterol LevelsGREENFEDER, Scott.Current medicinal chemistry. 2009, Vol 16, Num 2, pp 144-156, issn 0929-8673, 13 p.Article

Cloning and pharmacological characterization of mouse TRPV1CORRELL, Craig C; PHELPS, P. Tara; ANTHES, John C et al.Neuroscience letters. 2004, Vol 370, Num 1, pp 55-60, issn 0304-3940, 6 p.Article

Biochemical characterization of desloratadine, a potent antagonist of the human histamine H₁ receptorANTHES, John C; GILCHREST, Helen; EGAN, Robert W et al.European journal of pharmacology. 2002, Vol 449, Num 3, pp 229-237, issn 0014-2999Article

SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonistXIANHAI HUANG; JING SU; DONG XIAO et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 2, pp 854-858, issn 0960-894X, 5 p.Article

SCH 206272: a potent, orally active tachykinin NK₁, NK₂, and NK₃ receptor antagonistANTHES, John C; CHAPMAN, Richard W; RIZZO, Charles et al.European journal of pharmacology. 2002, Vol 450, Num 2, pp 191-202, issn 0014-2999Article

Tryptase-induced airway microvascular leakage in guinea pigs : involvement of tachykinins and leukotrienesGREENFEDER, Scott; SEHRING, Susan; MCHUGH, Nansie et al.European journal of pharmacology. 2001, Vol 419, Num 2-3, pp 261-267, issn 0014-2999Article

The IL-5 receptor on human bronchus selectively primes for hyperresponsivenessRIZZO, Charles A; YANG, Richard; GREENFEDER, Scott et al.Journal of allergy and clinical immunology. 2002, Vol 109, Num 3, pp 404-409, issn 0091-6749Article